Merrion Pharma to raise funds to develop products
Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.
Company has already raised $24m and now hopes to develop drug delivery technology through flotation, writes Gavin Daly.
Merrion Pharmaceuticals, the Dublin Firm that plans to list in Ireland and the US next month, is betting on investor interest in the potential of its drugs.
The company has a limited trading history, with turnover of just over $200,000 (€150,000) from the time it was founded in December 2003 to the end of September last year.
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
The year in review
The best writing and and the biggest stories of 2019 from the Business Post
Newsround: What Thursday’s papers say
Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals
More cycle routes, expansion of Luas to Bray and new bus network proposed
Greater Dublin Area draft Transport Strategy published
